This raises critical questions: whether there exists an ac4C deacetylase that reverse-regulates this modification network, and whether NAT10 exerts tumor-suppressive functions through maintaining mRNA structural homeostasis of proto-oncogenes. The gene discussed is NAT10; the disease is neoplasm.